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With this issue of volume 3, we come to an end and a
beginning. We are at a momentous threshold, one that begins
with a glimmer of recognition that our efforts have been on
target. How do I know this? Let me count the ways! First, there
was at the end of June 2006, a palpable increase in the numbers
of PDF downloads. In fact the 100000 or so for volume 1 in
2004 was superceded impressively by 150000 for volume 2 in
2005 to a remarkable 150000 for one-half of volume 3, 2006.
Let us see what happens at this year’s end as we enthusias-
tically open the covers for volume 4. What is waiting in the
papers? With the end of volume 3 will the level rise to
200000? And if so it would be of interest to know if com-
parable numbers exist for CAM journals first and foremost
and for other journals that publish work that encompasses a
variety of disciplines.
Almost 4 years ago, when eCAM was just an embryo, we
were forming our editorial concept for the journal. At that time
we envisioned a place where scientists could discuss with
philosophers and historians as well as the practitioners of
all the modalities of CAM. Often when we send a more
philosophically or historically oriented paper to reviewers,
they question its place in eCAM. Just as an idea without
evidence can lead one astray so, too, can evidence without a
continuing discussion of the ideas that initiated its discovery.
In recent issues, we have published articles that seek a
scientific evidence base for ‘ki’ (1–3) and now in this issue we
open up the concept more philosophically with a commentary,
‘What is Qi?’(4).
In these first three volumes, has our eclectic approach
enabled us to carve out a niche in CAM? I think so and I am
optimistic that an even greater impact is ahead. So what are
our new directions for the next volume? Around us, we can see
the growing need for approaches to the pressing problems
created by older populations in industrialized countries. In
other parts of the world, we see the need for cures of infectious
diseases that are shortening the life spans of huge populations.
And we all share the threat of pandemics about which it is
important to remember that the solutions during the SARS
epidemic were sought and found within traditional Chinese
medicine. Increasingly, the world is turning to CAM (includ-
ing traditional) modalities to both ameliorate and prevent these
extreme conditions that are the source of suffering.
As inaugurated in the first editorial of this volume, our
recent efforts to be more inclusive of clinical work have been
rewarded by a beginning flow of clinical papers. To aid the
process, Writer’s Workshops have been successfully convened
on both sides of the Pacific and can serve as a model for others
(5–7). In fact, another is scheduled for Pune, India, November
2006 (8). While we actively search for stronger and more
competitive clinical works, we will encourage reviews that
take us far off into the future of science by exploring new
areas such as nanosystems and their applicability (9). We will
continue to rely on the applicability and relevance of animal
models and the efficacy and less controversial in vitro models.
We hope that interpreters and liaison makers who will be
able to extend the accrued technology and apply it to the
human condition take up these in vitro models. These data will
engender even more ideas and questions and again data in the
endless process of scientific inquiry.
With the increasing number of readers, we have also
experienced an encouraging rise in submissions. How has
this changed eCAM? Certainly, we are faced with the need to
reject more of the manuscripts that arrive at our door. While
our assessment of original research papers and clinical work
must by necessity become more and more rigorous, we strive
to keep an open mind to commentaries and hypotheses. In the
process of organizing an issue, we often use the word ‘round’
to describe an article or combination of articles. Is the issue
‘round’ enough? Does it offer food for thought as well as hard
scientific evidence? Since many important discoveries began
with a question, we hope that you come to eCAM searching
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you on a new and exciting path.
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